Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+2.98%
|
-
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+4.94%
|
$62,500
$2.48 P/Share
|
Nov 29
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.75 P/Share
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.28%
|
$160,000
$10.96 P/Share
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.79%
|
$16,000
$1.06 P/Share
|
Nov 16
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
Nov 16
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
17,770
-0.23%
|
$195,470
$11.12 P/Share
|
Nov 15
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,751
-1.0%
|
$63,261
$11.86 P/Share
|
Nov 15
2022
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-0.18%
|
$11,715
$11.86 P/Share
|
Nov 15
2022
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-0.71%
|
$15,983
$11.86 P/Share
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.52%
|
$120,000
$12.31 P/Share
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.09%
|
$10,000
$2.22 P/Share
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.69%
|
$6,743
$11.86 P/Share
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$25,000
$10.1 P/Share
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,693
-3.09%
|
$366,930
$10.0 P/Share
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.02%
|
-
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.0%
|
$62,500
$2.48 P/Share
|
Oct 27
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,551,020
+18.43%
|
$22,959,180
$9.8 P/Share
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.24%
|
$160,000
$10.72 P/Share
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
Oct 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.2%
|
$100,000
$10.92 P/Share
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.82%
|
$10,000
$2.22 P/Share
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$27,500
$11.64 P/Share
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,053
-3.1%
|
$396,583
$11.58 P/Share
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.08%
|
-
|
Oct 06
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.11%
|
$62,500
$2.48 P/Share
|
Oct 03
2022
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,092
+0.18%
|
-
|
Oct 03
2022
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,725
+4.94%
|
-
|
Oct 03
2022
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,265
+0.8%
|
-
|
Oct 03
2022
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
920
+0.01%
|
-
|
Oct 03
2022
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+16.38%
|
-
|
Sep 29
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-3.62%
|
$176,000
$11.2 P/Share
|
Sep 29
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
Sep 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
Sep 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.84%
|
$130,000
$13.66 P/Share
|
Sep 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.6%
|
$10,000
$2.22 P/Share
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$25,000
$10.5 P/Share
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,566
-3.22%
|
$365,660
$10.34 P/Share
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.16%
|
-
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.22%
|
$62,500
$2.48 P/Share
|
Aug 17
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.55%
|
-
|
Aug 16
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-23.3%
|
$360,000
$12.61 P/Share
|
Aug 16
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+16.26%
|
$50,000
$2.22 P/Share
|
Aug 16
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-5.14%
|
$192,000
$12.6 P/Share
|
Aug 16
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
Aug 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.59%
|
$7,356
$12.96 P/Share
|